Quality of life at initial presentation in patients with gynaecological malignancies: a cross-sectional study from a tertiary care centre in India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260557Keywords:
Emotional distress, FACT-G, Gynaecological cancer, India, Quality of lifeAbstract
Background: Gynaecological malignancies are associated with significant physical, psychological, social, and functional morbidity, often beginning at the time of diagnosis. Quality of life (QOL) assessment at baseline remains underexplored in the Indian setting. This study aimed to evaluate the quality of life of patients with gynaecological cancers at the time of initial presentation using the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire.
Methods: This cross-sectional observational study included 70 newly diagnosed, treatment-naïve patients with gynaecological malignancies presenting to a tertiary care hospital in North India. QOL was assessed using the interviewer-administered FACT-G questionnaire, comprising physical, social, emotional, and functional well-being domains. Descriptive statistical analysis was performed.
Results: Pain was the most frequently reported physical symptom, affecting 73% of patients. Emotional distress was highly prevalent, with 78% reporting sadness and fear of dying. Social well-being was compromised, with 88% reporting lack of closeness to friends and 70% dissatisfaction with sexual life. Overall, 76% of patients were dissatisfied with their current quality of life.
Conclusions: Quality of life was significantly impaired across multiple domains at the time of diagnosis of gynaecological cancers. Early identification of QOL deficits and integration of supportive and psychosocial care from the outset of cancer management are essential to improve patient-centered outcomes.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209-49. DOI: https://doi.org/10.3322/caac.21660
Mehnert A, Hartung TJ, Friedrich M, Vehling S, Brähler E, Härter M, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psycho‐oncol. 2018;27(1):75-82. DOI: https://doi.org/10.1002/pon.4464
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570-9.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9. DOI: https://doi.org/10.1200/JCO.1993.11.3.570
Zhu B, Gu H, Mao Z, Beeraka NM, Zhao X, Anand MP, et al. Global burden of gynaecological cancers in 2022 and projections to 2050. J Glob Heal. 2024;14:04155. DOI: https://doi.org/10.7189/jogh.14.04155
Schag CA, Heinrich RL, Aadland RL, Ganz PA. Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. Health Psychol. 1990;9(1):83. DOI: https://doi.org/10.1037//0278-6133.9.1.83
Snaith RP. The hospital anxiety and depression scale. Health and quality of life outcomes. 2003;1(1):29. DOI: https://doi.org/10.1186/1477-7525-1-29
Lim L, Machingura A, Taye M, Pe M, Coens C, Martinelli F, et al. Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study. eClinical Medicine. 2025;82:103153. DOI: https://doi.org/10.1016/j.eclinm.2025.103153
Saevarsdottir T, Fridriksdottir N, Gunnarsdottir S. Quality of life and symptoms of anxiety and depression of patients receiving cancer chemotherapy: longitudinal study. Cancer Nurs. 2010;33(1):E1-0. DOI: https://doi.org/10.1097/NCC.0b013e3181b4adb5
Hay CM, Donovan HS, Hartnett EG, Carter J, Roberge MC, Campbell GB, et al. Sexual health as part of gynecologic cancer care: what do patients want?. Int J Gynecol Cancer. 2018;28(9):1737-42. DOI: https://doi.org/10.1097/IGC.0000000000001376
de la Torre-Luque A, Gambara H, López E, Cruzado JA. Psychological treatments to improve quality of life in cancer contexts: A meta-analysis. Int J Clin Heal Psychol. 2016;16(2):211-9. DOI: https://doi.org/10.1016/j.ijchp.2015.07.005
Nayak M, George A, Vidyasagar M, Mathew S, Nayak S, Nayak B, et al. Quality of life among cancer patients. Indian J Palliat Care. 2017;23(4):445. DOI: https://doi.org/10.4103/IJPC.IJPC_82_17
Korankulangara T, Katta A, Kirtania M, Sulaiman D. Health-related quality of life in patients with cancer in India: a systematic review. Natl J Community Med. 2024;15(07):591-605. DOI: https://doi.org/10.55489/njcm.150720244063
Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):421-31. DOI: https://doi.org/10.1586/erp.11.41
Keerthana K, Subhaprada SC. Assessment of Quality of Life in Cervical Cancer Patients at a Tertiary Care Centre. Med J Dr DY Patil Vidyapeeth. 2024;17(Suppl 1):S171-7. DOI: https://doi.org/10.4103/mjdrdypu.mjdrdypu_149_24
Castro EM, Asencio G, Quinn GP, Brandon T, Gwede CK, Vadaparampil S, et al. Importance of and satisfaction with psychosocial support among cancer patients and survivors in Puerto Rico: Gender, Health Status, and Quality of Life Associations. Puerto Rico Heal Sci J. 2017;36(4):205.
Downloads
Published
How to Cite
Issue
Section
